American Portfolios Advisors Jounce Therapeutics, Inc. Transaction History

American Portfolios Advisors

  • $2.36 Trillion
  • Q3 2022

A detailed history of American Portfolios Advisors transactions in Jounce Therapeutics, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 1,650 shares of JNCE stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,650
Holding current value
$0
% of portfolio
0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023
BUY
$2.73 - $4.92 $4,504 - $8,118
1,650 New
1,650 $3.86 Million
Q4 2020

Mar 22, 2023
BUY
$6.37 - $10.33 $955 - $1,549
150 Added 9.09%
1,800 $12.6 Million
Q3 2020

Mar 22, 2023
BUY
$4.58 - $10.95 $687 - $1,642
150 Added 9.09%
1,800 $14.7 Million
Q2 2020

Mar 24, 2023
BUY
$4.17 - $7.58 $1,876 - $3,411
450 Added 28.13%
2,050 $14.1 Million
Q1 2020

Mar 24, 2023
SELL
$2.91 - $8.7 $145 - $434
-50 Reduced 3.03%
1,600 $7.6 Million
Q4 2019

Mar 24, 2023
SELL
$2.81 - $9.21 $843 - $2,763
-300 Reduced 18.18%
1,350 $11.8 Million
Q2 2019

Mar 24, 2023
SELL
$4.3 - $6.73 $4,515 - $7,066
-1,050 Reduced 63.64%
600 $2.97 Million
Q3 2018

Mar 24, 2023
SELL
$6.5 - $8.37 $3,575 - $4,603
-550 Reduced 33.33%
1,100 $7.15 Million
Q2 2018

Mar 24, 2023
SELL
$7.27 - $21.88 $3,998 - $12,034
-550 Reduced 33.33%
1,100 $8.43 Million

Others Institutions Holding JNCE

# of Institutions
4
Shares Held
720K
Call Options Held
0
Put Options Held
0
View Full List

About Jounce Therapeutics, Inc.

JNCE Quotes by TradingView
  • Ticker JNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,694,200
  • Description
  • Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...
More about JNCE
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email